References
- Amerio, A., Lugo, A., Stival, C., Fanucchi, T., Gorini, G., Pacifici, R., Odone, A., Serafini, G., & Gallus, S. (2021). COVID-19 lockdown impact on mental health in a large representative sample of Italian adults. Journal of Affective Disorders, 292, 398–404. https://doi.org/https://doi.org/10.1016/j.jad.2021.05.117
- Bartels, C., Hessmann, P., Schmidt, U., Vogelgsang, J., Ruhleder, M., Kratzenberg, A., Treptow, M., Reh-Bergen, T., Abdel-Hamid, M., Heß, L., Meiser, M., Signerski-Krieger, J., Radenbach, K., Trost, S., Schott, B. H., Wiltfang, J., Wolff-Menzler, C., & Belz, M. (2021). Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: a longitudinal study on patients with pre-existing mental disorders. European Archives of Psychiatry and Clinical Neuroscience, Epub ahead of print. https://doi.org/https://doi.org/10.1007/s00406-021-01351-y
- Bhugra, D., Molodynski, A., & Gnanapragasam, S. N. (2021). COVID-19 pandemic, mental health care, and the UK. Industrial Psychiatry Journal, 30(Suppl 1), S5–S9. https://doi.org/https://doi.org/10.4103/0972-6748.328862
- Blithikioti, C., Nuño, L., Paniello, B., Gual, A., & Miquel, L. (2021). Impact of COVID-19 lockdown on individuals under treatment for substance use disorders: Risk factors for adverse mental health outcomes. Journal of Psychiatric Research, 139, 47–53. https://doi.org/https://doi.org/10.1016/j.jpsychires.2021.05.006
- Brorson, H. H., Arnevik, E. A., Rand-Hendriksen, K., & Duckert, F. (2013). Drop-out from addiction treatment: A systematic review of risk factors. Clinical Psychology Review, 33(8), 1010–1024. https://doi.org/https://doi.org/10.1016/j.cpr.2013.07.007
- Bruine de Bruin, W. (2021). Age differences in COVID-19 risk perceptions and mental health: Evidence from a national U.S. survey conducted in March 2020. The Journals of Gerontology, 76(2), e24–e29. https://doi.org/https://doi.org/10.1093/geronb/gbaa074
- Bulbena, A., Bobes, J., Luque, A., Dal-Ré, R., Ballesteros, J., & Ibarra, N. (2003). Validación de las versiones en español de la Clinical Anxiety Scale y del Physician Questionnaire para la evaluación de los trastornos de ansiedad. Medicina Clínica, 121(10), 367–374. https://doi.org/https://doi.org/10.1016/S0025-7753(03)73953-0
- Chang, W. H. (2020). Understanding the COVID-19 pandemic from a gender perspective. Taiwanese Journal of Obstetrics & Gynecology, 59(6), 801–807. https://doi.org/https://doi.org/10.1016/j.tjog.2020.09.004
- Dacosta-Sánchez, D., Fernández-Calderón, F., González-Ponce, B., Díaz-Batanero, C., & Lozano, Ó. M. (2019). Severity of substance use disorder: Utility as an outcome in clinical settings. Alcoholism: Clinical and Experimental Research, 43(5), 869–876. https://doi.org/https://doi.org/10.1111/acer.14020
- Daigre, C., Grau-López, L., Rodríguez-Cintas, L., Ros-Cucurull, E., Sorribes-Puertas, M., Esculies, O., Bones-Rocha, K., & Roncero, C. (2017). The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain. Quality of Life Research, 26(12), 3201–3209. https://doi.org/https://doi.org/10.1007/s11136-017-1668-4
- Daigre, C., Perea-Ortueta, M., Berenguer, M., Esculies, O., Sorribes-Puertas, M., Palma-Alvarez, R., Martínez-Luna, N., Ramos-Quiroga, J. A., & Grau-López, L. (2019). Psychiatric factors affecting recovery after a long term treatment program for substance use disorder. Psychiatry Research, 276, 283–289. https://doi.org/https://doi.org/10.1016/j.psychres.2019.05.026
- Daigre, C., Rodríguez, L., Roncero, C., Palma-Álvarez, R. F., Perea-Ortueta, M., Sorribes-Puertas, M., Martínez-Luna, N., Ros-Cucurull, E., Ramos-Quiroga, J. A., & Grau-López, L. (2021). Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit. Addictive Behaviors, 117, 106832 https://doi.org/https://doi.org/10.1016/j.addbeh.2021.106832
- Ferrer-Farré, T., Dinamarca, F., Mestre-Pintó, J. I., Fonseca, F., & Torrens, M. (2021). Dual disorders in the consultation liaison addiction service: Gender perspective and quality of life. Journal of Clinical Medicine, 10(23), 5572. https://doi.org/https://doi.org/10.3390/jcm10235572
- Gili, A., Bacci, M., Aroni, K., Nicoletti, A., Gambelunghe, A., Mercurio, I., & Gambelunghe, C. (2021). Changes in drug use patterns during the COVID-19 pandemic in Italy: Monitoring a vulnerable group by hair analysis. International Journal of Environmental Research and Public Health, 18(4), 1967. https://doi.org/https://doi.org/10.3390/ijerph18041967
- González-Blanco, L., Dal Santo, F., García-Álvarez, L., de la Fuente-Tomás, L., Lacasa, C. M., Paniagua, G., Sáiz, P. A., García-Portilla, M. P., & Bobes, J. (2020). COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls? Schizophrenia Research, 223, 192–198. https://doi.org/https://doi.org/10.1016/j.schres.2020.07.018
- González-Sanguino, C., Ausín, B., Castellanos, M. A., Saiz, J., & Muñoz, M. (2021). Mental health consequences of the Covid-19 outbreak in Spain. A longitudinal study of the alarm situation and return to the new normality. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 107, 110219. https://doi.org/https://doi.org/10.1016/j.pnpbp.2020.110219
- Grau-López, L., Daigre, C., Palma-Alvarez, R. F., Sorribes-Puertas, M., Serrano-Pérez, P., Quesada-Franco, M., Segura, L., Coronado, M., Ramos-Quiroga, J. A., & Colom, J. (2022). COVID-19 lockdown and consumption patterns among substance use disorder outpatients: A multicentre study. European Addiction Research, 2022, 1–12. https://doi.org/https://doi.org/10.1159/000521425
- Grau-López, L., Roncero, C., Daigre, C., Gonzalvo, B., Bachiller, D., Rodriguez-Cintas, L., Egido, Á., & Casas, M. (2012). Factores de riesgo de recaída en pacientes drogodependientes tras desintoxicación hospitalaria [Risk factors for relapse in drug-dependent patients after hospital detoxification]. Adicciones, 24(2), 115–122. https://doi.org/https://doi.org/10.20882/adicciones.103
- Guadagni, V., Umilta’, A., & Iaria, G. (2020). Sleep quality, empathy, and mood during the isolation period of the COVID-19 pandemic in the Canadian population: Females and women suffered the most. Frontiers in Global Women’s Health, 1, 585938. https://doi.org/https://doi.org/10.3389/fgwh.2020.585938
- Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology, Revised. US Department of Health, Education, and Welfare Publication (ADM), (pp. 76–338). National Institute of Mental Health.
- Hossain, M. M., Rahman, M., Trisha, N. F., Tasnim, S., Nuzhath, T., Hasan, N. T., Clark, H., Das, A., McKyer, E. L. J., Ahmed, H. U., & Ma, P. (2021). Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis. Heliyon, 7(4), e06677. https://doi.org/https://doi.org/10.1016/j.heliyon.2021.e06677
- Iudici, A., Girolimetto, R., Volponi, G., & Eletto, A. (2020). Dual diagnosis and application problems in the use of the construct: A review of literature. The Journal of Nervous and Mental Disease, 208(3), 181–189. https://doi.org/https://doi.org/10.1097/NMD.0000000000001092
- Martínez-Cao, C., de la Fuente-Tomás, L., Menéndez-Miranda, I., Velasco, Á., Zurrón-Madera, P., García-Álvarez, L., Sáiz, P. A., Garcia-Portilla, M. P., & Bobes, J. (2021). Factors associated with alcohol and tobacco consumption as a coping strategy to deal with the coronavirus disease (COVID-19) pandemic and lockdown in Spain. Addictive Behaviors, 121, 107003. https://doi.org/https://doi.org/10.1016/j.addbeh.2021.107003
- Morisano, D., Babor, T. F., & Robaina, K. A. (2014). Co-occurrence of substance use disorders with other psychiatric disorders: Implications for treatment services. Nordic Studies on Alcohol and Drugs, 31(1), 5–25. https://doi.org/https://doi.org/10.2478/nsad-2014-0002
- Nesoff, E. D., Marziali, M. E., & Martins, S. S. (2021). The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic. Addiction, 2021, 778. https://doi.org/https://doi.org/10.1111/add.15778
- Olié, E., Dubois, J., Benramdane, M., Guillaume, S., & Courtet, P. (2021). Psychological state of a sample of patients with mood disorders during the first French COVID-19 lockdown. Scientific Reports, 11(1), 23711. https://doi.org/https://doi.org/10.1038/s41598-021-03037-w
- Overall, J. E., Hollister, L. E., & Pichot, P. (1967). Major psychiatric disorders. A four-dimensional model. Archives of General Psychiatry, 16(2), 146–151. https://doi.org/https://doi.org/10.1001/archpsyc.1967.01730200014003
- Özdin, S., & Bayrak Özdin, Ş. (2020). Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. The International Journal of Social Psychiatry, 66(5), 504–511. https://doi.org/https://doi.org/10.1177/0020764020927051
- Pennanen-Iire, C., Prereira-Lourenço, M., Padoa, A., Ribeirinho, A., Samico, A., Gressler, M., Jatoi, N. A., Mehrad, M., & Girard, A. (2021). Sexual health implications of COVID-19 pandemic. Sexual Medicine Reviews, 9(1), 3–14. https://doi.org/https://doi.org/10.1016/j.sxmr.2020.10.004
- Santabárbara, J., Bueno-Notivol, J., Lipnicki, D. M., Olaya, B., Pérez-Moreno, M., Gracia-García, P., Idoiaga-Mondragon, N., & Ozamiz-Etxebarria, N. (2021). Prevalence of anxiety in health care professionals during the COVID-19 pandemic: A rapid systematic review (on published articles in Medline) with meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 107, 110244. https://doi.org/https://doi.org/10.1016/j.pnpbp.2021.110244
- Singh Balhara, Y. P., Szerman, N., Singh, S., Raga, J. M., Salom, C., Peris, L., & Ganesh, R. (2021). Treatment needs and service delivery for patients with dual disorders during the COVID-19 pandemic: Findings from the WADD Survey. Journal of Dual Diagnosis, 17(3), 248–256. https://doi.org/https://doi.org/10.1080/15504263.2021.1940413
- Soyka, M. (2017). Treatment of benzodiazepine dependence. The New England Journal of Medicine, 376(12), 1147–1157. https://doi.org/https://doi.org/10.1056/NEJMra1611832
- Taylor, S., Paluszek, M. M., Rachor, G. S., McKay, D., & Asmundson, G. J. G. (2021). Substance use and abuse, COVID-19-related distress, and disregard for social distancing: A network analysis. Addictive Behaviors, 114, 106754. https://doi.org/https://doi.org/10.1016/j.addbeh.2020.106754
- Thibaut, F., & van Wijngaarden-Cremers, P. J. M. (2020). Women’s mental health in the time of Covid-19 pandemic. Frontiers in Global Women’s Health, 1, 588372. https://doi.org/https://doi.org/10.3389/fgwh.2020.588372
- United Nations. (2020). World Drug Report 2020. Retrieved July 20, 2021, from https://wdr.unodc.org/wdr2020/field/WDR20_BOOKLET_1.pdf
- Xiong, P., Ming, W. K., Zhang, C., Bai, J., Luo, C., Cao, W., Zhang, F., & Tao, Q. (2021). Factors influencing mental health among Chinese medical and non-medical students in the early stage of the COVID-19 pandemic. Frontiers in Public Health, 9, 603331 https://doi.org/https://doi.org/10.3389/fpubh.2021.603331